Johnson & Johnson Has Increased Its Dividend for 64 Consecutive Years. Here's How Much $10,000 Invested Pays Annually.
Key Points
The company's dividend yield is not high, but the stock has also delivered strong price appreciation.
Very few publicly traded stocks have a longer streak of rising dividends.
- 10 stocks we like better than Johnson & Johnson ›
If you're not aware of them, there's a group of stocks known as Dividend Kings. This select group of companies have all increased their dividends annually for at least 50 consecutive years.
A few of these Dividend Kings have done much better. Drug and medical device maker Johnson & Johnson (NYSE: JNJ) recently increased its dividend for the 64th consecutive year. Only nine publicly traded stocks can claim a longer streak of rising dividends.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Image source: Getty Images.
What does that mean for J&J shareholders? Well, in April, Johnson & Johnson declared a 3.1% increase to its quarterly dividend, from $1.30 per share to $1.34. That makes its new annual dividend $5.36 a share.
If you own $10,000 in J&J stock, that would be equal to about 38 shares at the current share price of about $260. That means that the investment would yield about $204 a year in dividend income.
To be sure, that's not a king's ransom, because J&J's forward dividend yield -- the ratio of its dividend to its share price -- is a modest 2.07%. Many stocks in the S&P 500 pay higher dividend yields, with some exceeding 5%.
But in addition to its dividend, Johnson & Johnson stock has delivered strong price appreciation in recent years. The stock is up 50% over the past 52 weeks and has climbed 26% in 2026. Compare that to the broader market as measured by the S&P 500, which is up 21.6% over the past year and 13% this year.
So, with J&J stock, you're getting both growth and income.
Should you buy stock in Johnson & Johnson right now?
Before you buy stock in Johnson & Johnson, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Johnson & Johnson wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $400,209!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,375,393!*
Now, it’s worth noting Stock Advisor’s total average return is 964% — a market-crushing outperformance compared to 215% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of August 13, 2026.
Matthew Benjamin has no position in any of the stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool has a disclosure policy.
Recommended Articles
